#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2982	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2944	240.6	0	.	n	.	0	C451T	SNP	451	451	C	1093	1093	T	329	T,G,C	311,5,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2982	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2944	240.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1826	1826	C	297	C	286	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5762	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4282	329.9	0	.	n	.	0	T695C	SNP	695	695	T	1381	1381	C	340	C,G	317,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5762	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4282	329.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2657	2657	C	463	C,T	439,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5762	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4282	329.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2731	2731	A	471	A	451	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5762	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4282	329.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3283	3283	C	437	C,A	419,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5762	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4282	329.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2324	2324	A	391	A,G	182,196	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	972	folP	855	855	100.0	folP.l15.c4.ctg.1	2141	108.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1396	1398	AGC	125;126;124	A,G;G;C	122,1;124;120	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	1	SNP	p	S91F	1	.	.	271	273	TTC	920	922	TTC	81;81;81	T;T;C	72;74;78	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	1	SNP	p	G95N	0	.	.	283	285	GGC	932	934	GGC	86;88;89	G,C;G;C	83,1;85;82	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	1	SNP	p	D95G	1	.	.	283	285	GGC	932	934	GGC	86;88;89	G,C;G;C	83,1;85;82	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	0	HET	.	.	.	C2313G	.	2313	2313	C	2962	2962	C	130	C,G	72,9	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	0	HET	.	.	.	G2321C,A	.	2321	2321	G	2970	2970	G	124	G,C,A	65,10,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1704	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4086	102.1	0	HET	.	.	.	G2377A	.	2377	2377	G	3026	3026	G	92	G,A	55,10	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	752	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2023	91.6	1	SNP	p	G45D	0	.	.	133	135	GGC	832	834	GGC	215;215;215	G;G,A;C	205;198,1;204	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	524	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1770	71.9	0	.	n	.	0	A197.	DEL	197	197	A	981	981	A	173	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	1	SNP	p	D86N	0	.	.	256	258	GAC	961	963	GAC	102;102;104	G;A,C,T;C	77;59,1,1;86	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	1	SNP	p	R87I	0	.	.	259	261	CGT	964	966	CGT	104;105;107	C;G;T,G	96;76;90,2	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	1	SNP	p	R87W	0	.	.	259	261	CGT	964	966	CGT	104;105;107	C;G;T,G	96;76;90,2	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	1	SNP	p	S87R	1	.	.	259	261	CGT	964	966	CGT	104;105;107	C;G;T,G	96;76;90,2	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	1	SNP	p	S88P	0	.	.	262	264	TCC	967	969	TCC	107;107;107	T;C,T,A;C,T	101;97,1,1;99,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	155	1834	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3577	124.4	0	HET	.	.	.	T1526G,A	.	1526	1526	T	2231	2231	T	136	T,G,A	106,21,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1758	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3508	122.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1993	1995	GGC	147;147;147	G;G;C	131;129;117	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1634	1636	GCC	113;114;114	G,A;C,G;C	108,1;111,1;111	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1637	1639	ATG	114;114;114	A;T,C;G,T	112;109,1;108,2	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1649	1651	ACC	116;116;116	A,C;C,A;C	112,1;113,1;114	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1649	1651	ACC	116;116;116	A,C;C,A;C	112,1;113,1;114	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2150	2152	ACC	69;68;65	A;C;C	50;57;61	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2204	2206	GCG	68;68;69	G;C,G;G,C,A	64;57,1;53,1,1	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2204	2206	GCG	68;68;69	G;C,G;G,C,A	64;57,1;53,1,1	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2327	2329	GGT	70;70;70	G;G,T;T,C,G	70;64,6;67,2,1	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2336	2338	GGC	65;65;65	G;G,C;C	61;51,1;40	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2354	2356	CCG	67;65;65	C,T,G;C,A;G,A	53,2,1;51,1;55,1	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	155	992	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2753	86.3	0	HET	.	.	.	T794G	.	794	794	T	1497	1497	T	127	T,G	96,11	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	R379S	NONSYN	1135	1137	CGC	2210	2212	GCC	93;92;92	G,C,T;C;C,A	78,4,1;87;88,2	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	A385G	NONSYN	1153	1155	GCC	2192	2194	CCG	91;90;91	C;C,G;G,C	80;68,1;82,4	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	A387G	NONSYN	1159	1161	GCG	2186	2188	CTC	95;94;93	C,A;T,C,A;C	69,1;45,2,1;72	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	V388G	NONSYN	1162	1164	GTC	2183	2185	CCG	97;95;95	C;C;G,T	88;80;49,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	D389W	NONSYN	1165	1167	GAT	2180	2182	CGA	95;95;95	C;G,C;A,C,G	78;59,4;61,3,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	E391G	NONSYN	1171	1173	GAG	2174	2176	CAT	95;99;98	C,A;A,C;T,A,G	92,2;96,2;93,1,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	M393K	NONSYN	1177	1179	ATG	2168	2170	TTT	105;104;102	T;T,A;T	102;100,1;100	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	E395G	NONSYN	1183	1185	GAG	2162	2164	CCC	105;105;107	C;C,G;C	98;99,1;103	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	D396G	NONSYN	1186	1188	GAC	2159	2161	CCT	105;105;105	C,T;C;T,C	91,1;86;64,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	0	.	p	.	0	R397S	NONSYN	1189	1191	CGT	2156	2158	GGT	104;104;104	G,T;G,A,T;T,G	95,1;82,1,1;78,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	795	1318	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	4352	74.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2082	2084	GGC	112;112;111	G,A;G;C,G	84,2;97;79,6	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	562	porA	1146	1146	99.91	porA.l15.c30.ctg.1	2347	57.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	690	690	C	43	C,A	33,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2466	62.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	850	852	GTT	99;97;97	G;T;T	95;91;93	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2466	62.2	0	.	p	.	0	E209K	NONSYN	625	627	GAA	1342	1344	AAA	82;82;82	A;A;A	80;80;80	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2466	62.2	1	SNP	p	G120K	1	.	.	358	360	AAG	1075	1077	AAG	81;81;80	A,C;A,C;G,A,C	77,3;80,1;76,2,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2466	62.2	1	SNP	p	N121D	0	.	.	361	363	AAC	1078	1080	AAC	81;81;80	A;A;C,A	81;81;77,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	618	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2466	62.2	1	SNP	p	A121N	1	.	.	361	363	AAC	1078	1080	AAC	81;81;80	A;A;C,A	81;81;77,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1936	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5592	85.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	214	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1794	29.3	1	SNP	p	V57M	1	.	.	169	171	ATG	895	897	ATG	60;62;62	A;T;G,T	56;60;59,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
